ClinicalTrials.gov
public full text
Public Domain
Evaluation of [18F] FMH3 and PET as a Marker of Histamine-3 Receptor Activity in Subjects With AD Compared w/ HC
The underlying goal of this study is to assess \[18F\]-FMH3 PET imaging as a tool to evaluate the activity of the H3 receptor in the brain of Alzheimer Disease (AD) research participants
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Three-Photon LIF Imaging of Atomic Hydrogen in Plasma-assisted CH4/air combustion#1159482
- Does Evolutionary Psychology Show That Normativity Is Mind-Dependent?#700704
- Multiobjective V(H)H discovery through integrated high-throughput screening and AlphaFold3-guided structural prioritization.#1158730
- Dietary diversity, migration experience, and brain volume in middle-aged and older adults in rural Japan: a cross-sectional magnetic resonance imaging study.#360532
- Mapping Individual Neuroanatomical Alterations to Schizophrenia Psychopathology with Normative Modeling#395182
Record · ID 1044470
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive